DFine rakes in $30m for spine surgical tech
This article was originally published in Clinica
Executive Summary
San Jose, California-based orthopaedic company DFine has secured $30m in series D financing, which it will use to expand commercialisation of its minimally-invasive spinal surgery technology. The financing was led by BBT Fund and Highland Capital Management. The company's StabiliT vertebral augmentation system is designed to treat vertebral compression fractions caused by osteoporosis or cancer. The system injects a bone cement, made from a proprietary energy-responsive polymethymethacrylate (PMMA) formulation, into the fractured vertebral column to stabilise the spine. The StabiliT is able to increase the viscosity of the cement by applying energy to the material. The system is commercially available in the US, and can be used only for clinical investigation in Europe.